(ROIV) - Corporate News

(ROIV) – Corporate News

Apr 2, 2024 07:02 AM Roivant Sciences (ROIV) Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, $1.5B Share Buyback
Dec 20, 2023 04:30 PM Immunovant (IMVT) Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
Nov 28, 2023 07:02 AM
Nov 27, 2023 08:00 AM
Nov 10, 2023 08:03 AM
Oct 23, 2023 06:25 AM
Oct 2, 2023 02:41 AM
Sep 26, 2023 06:47 AM
Sep 11, 2023 08:03 AM
Aug 2, 2023 04:10 PM
Jul 6, 2023 05:49 PM
Jun 22, 2023 07:30 AM
May 16, 2023 07:02 AM
Mar 15, 2023 07:46 AM
Feb 21, 2023 04:09 PM
Feb 3, 2023 05:54 AM
Feb 1, 2023 04:05 PM
Dec 1, 2022 08:05 AM
Nov 8, 2022 06:16 AM
Nov 7, 2022 04:01 PM
Sep 20, 2022 05:58 AM
Jun 28, 2022 06:11 AM
Jun 28, 2022 06:00 AM
May 24, 2022 06:01 AM
Feb 28, 2022 06:02 AM
May 3, 2021 07:01 AM